Board of Directors
Randeep Grewal (Chairman)
Randeep Grewal is a London-based ex-Fund manager with over 17 years of Healthcare investment experience including at Trium, F&C Asset Management, ICAP Equities and Tudor. Randeep trained as a Vascular and General Surgeon and read both Medicine and Computer Science at Cambridge University.
Josephine Dixon (Chair of the Audit Committee)
Josephine Dixon is a chartered accountant who sits on the boards of Standard Life Equity Income Trust, JP Morgan European Investment Trust, Strategic Equity Capital and BMO Global Smaller Companies. Her executive experience includes finance, governance and general commercial roles in a number of sectors.
Prof. Justin Stebbing
Prof. Justin Stebbing is a clinical oncologist and has published over 500 peer-reviewed papers on cancer and has played a leading role in finding uses for approved medicines in the treatment of COVID-19. He is a Fellow of the Royal College of Physicians, the American Board of Internal Medicine and the Royal College of Pathologists and sits on a number of advisory boards. He also has previous investment management experience as a healthcare analyst.
Kate Bolsover worked in the City of London for over 25 years, initially as an analyst and thereafter running the mutual fund businesses of both Baring Asset Management and Cazenove Fund Management. Latterly, she was appointed Director of Corporate Communications for JPMorgan Cazenove. Kate is Chairman of Fidelity Asian Values and is an independent director at Invesco Bond Income Plus, TR Property Investment Trust and Baillie Gifford & Co.
Professor Tony Young
Prof. Tony Young is a practicing frontline NHS surgeon, Associate Medical Director at the Mid and South Essex University Hospitals Group, Director of Medical Innovation at Anglia Ruskin University. In 2014 he was appointed as National Clinical Director for Innovation at NHS England and in February 2016 became the first National Clinical Lead for Innovation and played a leading role in co-ordinating the NHS response to the COVID-19 pandemic. In 2015 he founded the NHS Clinical Entrepreneur programme. In 2019 Tony was awarded the OBE for services to clinical leadership.
Paul Southgate is a London-based Portfolio Manager at PictetAsset Management, with over 21 years’ investment experience, including healthcare companies. Before joining Pictet, he was a Managing Partner at Eisenstat Capital Partners (ECAP) and managed European Equities for both Deephaven Capital and Fortress Investments Group. He began his career with UBS Asset Management.